Protagenic Therapeutics, Inc.\new Annual Interest Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Protagenic Therapeutics, Inc.\new quarterly/annual Interest Expense history and growth rate from 2014 to 2023.
  • Protagenic Therapeutics, Inc.\new Interest Expense for the quarter ending December 31, 2023 was $12.9K, a 59.8% decline year-over-year.
  • Protagenic Therapeutics, Inc.\new Interest Expense for the twelve months ending December 31, 2023 was $108K, a 21.7% decline year-over-year.
  • Protagenic Therapeutics, Inc.\new annual Interest Expense for 2023 was $108K, a 21.7% decline from 2022.
  • Protagenic Therapeutics, Inc.\new annual Interest Expense for 2022 was $137K, a 72.3% decline from 2021.
  • Protagenic Therapeutics, Inc.\new annual Interest Expense for 2021 was $497K, a 102% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $108K -$29.8K -21.7% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-05-14
2022 $137K -$359K -72.3% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
2021 $497K +$251K +102% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $246K Jan 1, 2020 Dec 31, 2020 10-K 2022-04-07
2016 $7.16K -$4.31K -37.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $11.5K +$8.47K +282% Jan 1, 2015 Dec 31, 2015 10-K/A 2017-05-08
2014 $3K Jul 12, 2013 Jun 30, 2014 10-K 2015-09-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.